Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite. (Q52541687)
Jump to navigation
Jump to search
scientific article published in October 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite. |
scientific article published in October 1994 |
Statements
Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite. (English)
K Randerath
B Moorthy
N Mabon
P Sriram
1 October 1994
15
10
2087-2094